Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT02954991. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Parallel Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Advanced or Metastatic Non-Small Cell Lung Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study will evaluate the clinical activity of nivolumab in combination with 3 separate investigational agents, glesatinib, sitravatinib, or mocetinostat.
Study identification
- NCT ID
- NCT02954991
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 161 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 7, 2016 (Actual)
- Primary completion
- Nov 4, 2021 (Actual)
- Completion
- Nov 4, 2021 (Actual)
- Last update posted
- Apr 22, 2024
2016 – 2021
United States locations
- U.S. sites
- 25
- U.S. states
- 14
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Yuma Regional Medical Center | Yuma | Arizona | 85364 | — |
| Beverly Hills Cancer Center | Beverly Hills | California | 90211 | — |
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| University of California San Diego | La Jolla | California | 92093 | — |
| University of California San Francisco Comprehensive Cancer Center | San Francisco | California | 94115 | — |
| University of California Los Angeles - Torrance - Community Cancer Care | Santa Clarita | California | 91355 | — |
| Rocky Mountain Cancer Centers - Denver - Midtown | Denver | Colorado | 80218 | — |
| Baptist Health | Louisville | Kentucky | 40207 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Minnesota Oncology Hematology, P.A. | Minneapolis | Minnesota | 55404 | — |
| University of Minnesota Masonic Cancer Center | Minneapolis | Minnesota | 55455 | — |
| Saint Francis Cancer Treatment Center | Grand Island | Nebraska | 68803 | — |
| Oncology Hematology Care-Blue Ash | Cincinnati | Ohio | 45242 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | — |
| Hematology Oncology Associates - Barnett Office | Medford | Oregon | 97504 | — |
| Northwest Cancer Specialists, P.C. | Tualatin | Oregon | 97062 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| Vanderbilt University | Nashville | Tennessee | 37212 | — |
| Texas Oncology - South Austin | Austin | Texas | 78745 | — |
| USOR - Texas Oncology - Denison Cancer Center | Denison | Texas | 75020 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Texas Oncology - Tyler | Tyler | Texas | 75702 | — |
| Virginia Cancer Specialist | Fairfax | Virginia | 22031 | — |
| University of Wisconsin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02954991, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2024 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02954991 live on ClinicalTrials.gov.